 | • レポートコード：MRC2303H213 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、251ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査資料によると、2021年に169.26百万ドルであった世界の脳・身体用オキシメーター市場規模は2022年に178.27百万ドルとなり、2027年までに年平均5.50％成長して233.39百万ドルまで拡大すると見込まれています。当書は、脳・身体用オキシメーターの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（デュアルエミッター＆デュアルディテクター、シングルエミッター＆デュアルディテクター）、患者タイプ別分析（成人、NICU、小児）、用途別分析（心臓手術、血管手術）、エンドユーザー別分析（外来手術センター、クリニック、病院）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書内の企業情報としては、Chem-Labs Ltd.、Edwards Lifesciences LLC、Harmamatsu Photonics K.K.、ISS, Inc.、Masimo Corporation、Medline Industries, Inc.、Medtronic PLC、Merck KGaA、Nihon Kohden Corporation、Nonin Medical, Inc.、Ornim Medical, Ltd.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の脳・身体用オキシメーター市場規模：種類別 - デュアルエミッター＆デュアルディテクターの市場規模 - シングルエミッター＆デュアルディテクターの市場規模 ・世界の脳・身体用オキシメーター市場規模：患者タイプ別 - 成人患者における市場規模 - NICU患者における市場規模 - 小児患者における市場規模 ・世界の脳・身体用オキシメーター市場規模：用途別 - 心臓手術における市場規模 - 血管手術における市場規模 ・世界の脳・身体用オキシメーター市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - クリニックにおける市場規模 - 病院における市場規模 ・世界の脳・身体用オキシメーター市場規模：地域別 - 南北アメリカの脳・身体用オキシメーター市場規模 アメリカの脳・身体用オキシメーター市場規模 カナダの脳・身体用オキシメーター市場規模 ブラジルの脳・身体用オキシメーター市場規模 ... - アジア太平洋の脳・身体用オキシメーター市場規模 日本の脳・身体用オキシメーター市場規模 中国の脳・身体用オキシメーター市場規模 インドの脳・身体用オキシメーター市場規模 韓国の脳・身体用オキシメーター市場規模 台湾の脳・身体用オキシメーター市場規模 ... - ヨーロッパ/中東/アフリカの脳・身体用オキシメーター市場規模 イギリスの脳・身体用オキシメーター市場規模 ドイツの脳・身体用オキシメーター市場規模 フランスの脳・身体用オキシメーター市場規模 ロシアの脳・身体用オキシメーター市場規模 ... - その他地域の脳・身体用オキシメーター市場規模 ・競争状況 ・企業情報 |
The Global Cerebral Somatic Oximeters Market size was estimated at USD 169.26 million in 2021 and expected to reach USD 178.27 million in 2022, and is projected to grow at a CAGR 5.50% to reach USD 233.39 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cerebral Somatic Oximeters to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Dual Emitter and Dual Detector and Single Emitter and Dual Detector.
Based on Patient Type, the market was studied across Adults, NICU, and Pediatrics.
Based on Application, the market was studied across Cardiac Surgery and Vascular Surgery.
Based on End User, the market was studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cerebral Somatic Oximeters market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cerebral Somatic Oximeters Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cerebral Somatic Oximeters Market, including Chem-Labs Ltd., Edwards Lifesciences LLC, Harmamatsu Photonics K.K., ISS, Inc., Masimo Corporation, Medline Industries, Inc., Medtronic PLC, Merck KGaA, Nihon Kohden Corporation, Nonin Medical, Inc., Ornim Medical, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., SparkFun Electronics Inc., and Stryker Sustainability Solutions, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cerebral Somatic Oximeters Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cerebral Somatic Oximeters Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cerebral Somatic Oximeters Market?
4. What is the competitive strategic window for opportunities in the Global Cerebral Somatic Oximeters Market?
5. What are the technology trends and regulatory frameworks in the Global Cerebral Somatic Oximeters Market?
6. What is the market share of the leading vendors in the Global Cerebral Somatic Oximeters Market?
7. What modes and strategic moves are considered suitable for entering the Global Cerebral Somatic Oximeters Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of neurological , cardiovascular disease and traumatic injuries
5.1.1.2. Increasing adoption of the cerebral oximeter
5.1.1.3. Expanding use of cerebral somatic oximeters in hemostasis and non-hemostasis applications
5.1.2. Restraints
5.1.2.1. High cost of the cerebral somatic oximeters
5.1.3. Opportunities
5.1.3.1. Advancements in development of software programs and advent of EHRs
5.1.3.2. Improved and expanded clinical use coupled with the quality of patient care
5.1.4. Challenges
5.1.4.1. Clinical and technical issues of cerebral and somatic near-infrared spectroscopy
5.2. Cumulative Impact of COVID-19
6. Cerebral Somatic Oximeters Market, by Type
6.1. Introduction
6.2. Dual Emitter and Dual Detector
6.3. Single Emitter and Dual Detector
7. Cerebral Somatic Oximeters Market, by Patient Type
7.1. Introduction
7.2. Adults
7.3. NICU
7.4. Pediatrics
8. Cerebral Somatic Oximeters Market, by Application
8.1. Introduction
8.2. Cardiac Surgery
8.3. Vascular Surgery
9. Cerebral Somatic Oximeters Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Hospitals
10. Americas Cerebral Somatic Oximeters Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cerebral Somatic Oximeters Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cerebral Somatic Oximeters Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Chem-Labs Ltd.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Edwards Lifesciences LLC
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Harmamatsu Photonics K.K.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. ISS, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Masimo Corporation
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Medline Industries, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Medtronic PLC
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Merck KGaA
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Nihon Kohden Corporation
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Nonin Medical, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Ornim Medical, Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. SparkFun Electronics Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Stryker Sustainability Solutions, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing